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What Is Alzheimer’s Disease? 
 
Alzheimer’s disease (often shortened to “Alzheimer’s” or “AD”) is a brain disease usually 
occurring in older people, although it is not a normal part of aging. Alzheimer’s disease causes a 
decline in thinking, memory, and language, personality changes, and certain changes in the brain, 
that gradually get worse over time. AD eventually results in the loss of ability to carry out the 
simplest daily tasks. 
 Alzheimer’s disease is the most common cause of dementia in old age. “Dementia” refers to a 
decline in multiple areas of mental function that interferes with ability to carry out daily 
activities. Not all people with dementia have Alzheimer’s disease. The term “Alzheimer’s 
disease” is reserved for patients with characteristic changes in the brain that are the hallmarks of 
the disease. These brain changes include damage and loss of nerve cells and their connections, 
tangled fibers, protein clumps, and inflammation. AD begins deep in the brain, as many as 10 to 
20 years before symptoms appear, and gradually spreads to other parts of the brain. 
The progression of Alzheimer’s disease occurs in seven stages, according to the Alzheimer’s 
Association  ( http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp). Stage 1 is “no 
impairment.” Stage 2 is marked by “very mild decline;” the person experiences memory lapses 
but no symptoms are detected by others or by a medical examination. Such symptoms may be 
due to age-related changes and not AD. Stage 3 is “mild cognitive decline,” when others begin to 
notice a person’s memory problems. AD may be diagnosed in some, but not all people with mild 
cognitive decline. In stages 4-7, the person goes from moderate to severe decline. The 
progression and course of AD vary widely from individual to individual. Expert medical opinion 
should be sought to diagnose Alzheimer’s disease since other conditions requiring different 
treatments may mimic AD or coexist with it. 
History 
Alzheimer’s disease is not a new condition; the frequent association of dementia and old age was 
known to ancient Greek and Roman physicians. However, the characteristic brain lesions found 
in people with AD were first described by the German physician Alois Alzheimer and by noted 
psychiatrist Emil Kraepelin in the early 20th century. Alzheimer published a classic paper in 1907 
describing the tangled fibers and clumps that are now called “neurofibrillary tangles” and 
“amyloid plagues,” in the brain of a woman in her fifties with dementia.  
Alzheimer’s disease, long considered an obscure neurologic condition, came to the research 
forefront in 1976 with the publication of a landmark editorial by Robert Katzman, a leading AD 
researcher. In this paper, Katzman argued that “Alzheimer disease” and “senile dementia” were 
the same disease and a leading cause of disability and death in the U.S. Before this time, neither 
Alzheimer’s disease nor senile dementia had been listed as causes of death in U.S. vital statistics 
reports. 
Alzheimer’s disease is becoming an issue of increasing public health importance as people live 
longer and many countries have aging populations. According to the Alzheimer’s Association, 
more than 5 million people are living with Alzheimer’s in the U.S.; by 2050, as many as 16 
million may be affected. For the first time since the U.S. government’s Healthy People reports 
began in 1979, Healthy People 2020 includes goals and objectives for Alzheimer’s disease.  
 (HealthyPeople.gov. Dementias Including Alzheimer’s Disease. Accessed 1/13/2011 from 
http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=7) 
What is dementia? 
Dementia is a general term for a decline in multiple areas of mental functioning such as memory, 
reasoning, and language so extensive that it interferes with daily life. Dementia is not a specific 
disease, but rather a group of symptoms that often accompanies a disease or condition. 
Two of the most common causes of dementia in older people are Alzheimer’s disease and 
vascular dementia. The latter condition is caused by a series of strokes or changes to the brain’s 
blood supply. A person may have both AD and vascular dementia. 
Other conditions causing memory loss or dementia include: 
• Drug side effects 
• Chronic alcoholism 
• Brain tumors/infections/blood clots 
• Vitamin B12 deficiency 
• Dehydration 
• High fever 
• Some thyroid, kidney, or liver disorders 
• Severe depression 
Identifying the cause of dementia is important because this may affect the treatment and 
prognosis. 
 
Who gets Alzheimer’s disease and why? 
The exact cause of Alzheimer’s disease is not known. Researchers believe that Alzheimer’s 
disease usually results from the combination of several genetic, familial, and environmental 
factors. Age, family history, and genetics are key risk factors. 
The greatest single risk factor for AD is advanced age. For unknown reasons, symptoms usually 
begin after age 60. Alzheimer’s disease is found in about 1 in 8 people aged 65 to 74. After age 
65, the number of people affected doubles every five years; AD affects nearly half of all people 
over 85.  
A person’s genetic makeup may also increase his or her risk of AD. In the common form of 
Alzheimer’s disease that develops after age 60, certain genes may place a person at higher risk of 
AD, but do not make developing the disease inevitable. People with one or two copies of a gene 
called APOE-e4, for example, are at increased risk of developing the disease. 
A rare, early-onset form of AD appears in family clusters and begins between the ages of 30 and 
60. Most cases of early-onset AD are believed to result from genetic mutations; early-onset AD 
accounts for less than 5 percent of cases. 
Other risk factors for AD are less well established, and may include severe or repeated head 
trauma, female gender (partly because women live longer), and cardiovascular disease. Good 
health habits and remaining physically and mentally active may delay or slow the course of the 
disease. 
What is mild cognitive impairment? 
People with mild cognitive impairment (MCI) have problems with memory, language, or other 
mental functions that are noticeable to others and can be detected by testing, but are not serious 
enough to interfere with daily activities. People with MRI have an increased risk of developing 
Alzheimer’s disease, especially if their main problem is memory (amnestic MCI). 
How do I know if I have/ a loved one has Alzheimer’s disease? 
Mild memory problems are sometimes an early sign of Alzheimer’s disease, but may simply be 
part of the aging process. The Alzheimer’s Association has compiled a checklist of 10 warning 
signs, available online at http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp 
AD should be diagnosed only by a physician; local chapters of the Alzheimer’s Association can 
help locate an experienced practitioner. 
What can I expect if I am/a loved one is diagnosed with Alzheimer’s disease?  
Alzheimer’s disease is a progressive disease for which there is no known cure. Certain 
medications or other interventions may help relieve symptoms or even slow the progression of 
the disease. The type, progression, and severity of mental changes in AD vary greatly. The 
course of the disease from the time of diagnosis varies according to age, sex, severity at 
diagnosis, and presence of other health conditions. People may live from three to twenty years 
after diagnosis. A four-minute captioned video is available at 
http://www.nia.nih.gov/Alzheimers/ADVideo/ .  
How can I search for Alzheimer’s on the Web? 
Selected Web sites (see below under Important Sites) 
A good place to begin researching Alzheimer’s on the Web is the U.S. National Library of 
Medicine’s MedlinePlus at http://www.nlm.nih.gov/medlineplus/alzheimersdisease.html. This 
site has clean, well-designed screens and a wide variety of materials including videos, easy-to-
read flyers, and information in multiple languages. 
 The Alzheimer’s Association at http://www.alz.org/ and ADEAR at 
http://www.nia.nih.gov/Alzheimers/ are also good one-stop shops. 
The resources listed above and some other good Alzheimer’s Web sites are listed under Important Sites. 
They give overviews of AD, answer frequently asked questions, and tell what to expect in the early, 
middle, and late stages. They can point the user to the latest research and news, help locate doctors and 
services, and discuss the latest treatments and clinical trials. They teach caregivers how to help patients 
and alleviate the stress of caregiving. These Web sites also help patients, families and friends stay socially 
connected through e-mail, discussion groups, forums, blogs, and social media.  
Commercial sites also sell products; users must be careful to distinguish educational content from 
promotional materials. 
Search Engines 
Many users prefer to begin their quest with a search engine such as Google 
(http://www.google.com) or Yahoo (http://www.yahoo.com/) to search the entire Web, or a 
portal such as Healthfinder.gov (http://www.healthfinder.gov/) may be used to search a group of 
Web sites. Google Scholar (http://scholar.google.com/ ) is useful when searching for scholarly 
articles, and Google Books (http://books.google.com/ ) when looking for books. The user may 
wish to restrict his/her search to the most recent five years.  
Recommended Search Terms:  
• Alzheimer’s Disease  
• Alzheimer’s 
• Alzheimer Disease  
• Primary Senile Degenerative Dementia 
• Alzheimer type dementia 
• Senile dementia  
• Presenile dementia 
Abbreviations Used in this Section (optional) 
AD: Alzheimer’s Disease 
Medical Specialties (optional) 
Geriatrics, Neurology, Psychiatry 
Important Sites:  
One-Stop Shops 
Alzheimer’s Association http://www.alz.org/ 
Founded in 1980,  the Alzheimer’s Association is the major U.S.-based voluntary health 
organization devoted to Alzheimer’s disease. The Association has local chapters and support 
groups across the U.S., and is a key resource for people interested in Alzheimer’s intormation, 
care, education, research, and advocacy. Users can sign up for weekly e-news (sent by e-mail or 
RSS feeds.), and participate in the Association’s online communication forum. The stages of 
Alzheimer’s disease are described at 
http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp  
ADEAR. Alzheimer’s Disease Education and Referral Center. 
http://www.nia.nih.gov/Alzheimers/ 
ADEAR, founded in 1990 is a service of the National Institute on Aging, one of the U.S. 
National Institutes of Health. It was established by the U.S. Congress to be an AD information 
center for  health professionals and laypeople. ADEAR is one of the best sources for reliable, 
unbiased information on all aspects of Alzheimer’s disease. Most resources are free; U.S.-
government produced publications are not copyrighted and may be freely reproduced. 
MedlinePlus: Alzheimer’s Disease. http://www.nlm.nih.gov/medlineplus/alzheimersdisease.html 
MedlinePlus is the “gold standard” for reliable consumer health information on all topics, not 
just Alzheimer’s diseases. Includes news, information on health conditions, a medical dictionary, 
drug directory, videos, interactive tutorials and other information for various audiences, 
including easy-to-read and other languages. Medlineplus has both non-copyrighted (U.S. 
government-produced – may be freely reproduced) and copyrighted materials. 
Other Good Sites 
AARP. Alzheimer’s disease: Learning Center. http://healthtools.aarp.org/learning-
center/alzheimers-disease  
Alzheimer’s Disease International.  http://www.alz.co.uk/ 
Alzheimer’s Society (United Kingdom). http://www.alzheimers.org.uk/ 
Alzheimer Society (Canada). http://www.alzheimer.ca/english/index.php  
Mayo Clinic. Alzheimer’s Disease. http://www.mayoclinic.com/health/alzheimers-
disease/DS00161 
Includes multimedia materials, blog, newsletter. 
MedicineNet.com. Alzheimer’s Disease Center. 
http://www.medicinenet.com/alzheimers/focus.htm 
Merck Manual Home Edition. Alzheimer’s Disease. 
http://www.merckmanuals.com/home/sec06/ch083/ch083c.html#sec06-ch083-ch083c-522 
National Institute of Neurological Disorders and Stroke (NINDS): Alzheimer’s Disease. 
http://www.ninds.nih.gov/disorders/alzheimersdisease/alzheimersdisease.htm 
NIH Senior Health: Alzheimer’s Disease. http://nihseniorhealth.gov/alzheimersdisease/toc.html 
U.S. government site – text size may be adjusted and accompanying audio turned on/off. 
Includes videos. 
WebMD. Alzheimer’s Disease Health Center. http://www.webmd.com/alzheimers/default.htm 
Hotlines  
Many hotlines now use Skype. Skype allows computer users to download free software from 
http://www.skype.com/ and to make video phone calls free of charge if your computer has a 
webcam (a device that displays your picture and lets you see the person you are calling on the 
computer screen). 
1(800) 272-3900 (Alzheimer’s Association). 24-hour helpline. A Skype link appears on the 
association Web site.  
1(800) 438-4380 (ADEAR). A Skype link appears on the ADEAR Web site. 
1(866) AFA-8484 (Alzheimer’s Foundation of America). Talk to a social worker. Skype link 
available. 
Publications on the Internet  
Alzheimer’s Association. States of Alzheimer’s. 
http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp 
Alzheimer’s Association. 10 Signs of Alzheimer’s. 
http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp 
Healthy People 2020. Dementias Including Alzheimer’s. 
http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=7 
National Institute on Aging. Alzheimer’s Disease Fact Sheet. 
http://www.nia.nih.gov/Alzheimers/Publications/adfact.htm 
National Institute on Aging. Alzheimer’s Disease: Unraveling the Mystery (4-minute captioned 
video). http://www.nia.nih.gov/Alzheimers/ADVideo/  
National Institute on Aging. Understanding Alzheimer’s disease (easy to read) 
http://www.nia.nih.gov/Alzheimers/Publications/UnderstandingAD/  
PBS. The Forgetting: A Portrait of Alzheimer’s. (award-winning video and educational 
materials). http://www.pbs.org/theforgetting/  
Patient Support Organizations/Discussion Groups 
Alzheimer’s Association. Support Groups. 
http://www.alz.org/mglc/in_my_community_support.asp#connect_online 
WebMD Alzheimer’s Community. http://exchanges.webmd.com/alzheimers-exchange  
 
 
 
